Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 147

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 3
Chunk 147
---
a company provide otherwise, a transaction with an office holder or with a third party in which the office holder has a personal interest
that is not an extraordinary transaction and an action of an office holder that would otherwise be deemed a breach of duty of loyalty
that may have a material impact on a company’s profitability, assets or liabilities, requires approval by the board of directors.
Our Articles of Association do not provide otherwise. If the transaction or action considered is (i) an extraordinary transaction or (ii)
an action of an office holder that would otherwise be deemed a breach of duty of loyalty and may have a material impact on a company’s
profitability, assets or liabilities, then audit committee approval is required prior to approval by the board of directors.

Approval of compensation of office holders

  Executive officers other than the Chief Executive                                                                                               
  Officer. The compensation of an office holder in a public company who is neither a director nor the chief executive officer                     
  generally requires approval by the (i) compensation committee; and (ii) the board of directors. Approval of terms of office and                 
  employment for such officers which do not comply with the compensation policy may nonetheless be approved, in special circumstances, subject    
  to two cumulative conditions: (i) the compensation committee and thereafter the board of directors, approved the terms after having taken       
  into account the various considerations and mandatory requirements set forth in the Companies Law with respect a compensation policy,           
  and (ii) the shareholders of the company have approved the terms by the Special Majority for Compensation. However, if the shareholders         
  do not approve a compensation arrangement with an executive officer that is inconsistent with the company’s compensation policy,                
  a company’s compensation committee and board of directors, may, in special circumstances approve the compensation despite shareholder           
  objection, provided that the compensation committee and thereafter the board of directors have determined to approve the compensation           
  based on detailed reasoning, after each having re- discussed the terms of compensation, and after examining the objection of the shareholders.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Chief Executive Officer. The compensation                                                                                                         
  of a chief executive officer in a public company generally requires approval by the (i) compensation committee; (ii) the board of directors;      
  and (iii) the shareholders of the company by the Special Majority for Compensation. Approval of the compensation terms of a chief executive       
  officer which do not comply with the compensation policy may nonetheless